Medicines News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.09.15	MATRIX Trial Results Presented at Hot Line Session of ESC Congress 2015 and Simultaneously Published in The New England Journal of Medicine (Businesswire)
01.09.15	Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach (Businesswire)
30.08.15	ALN-PCS Phase 1 Clinical Trial Shows Positive Results (RTTNews)
30.08.15	Alnylam, Medicines cholesterol drug lasts months after one shot (Reuters)
24.08.15	The Medicines Company Announces Participation at 2015 European Society of Cardiology (ESC) Congress in London (Businesswire)
16.07.15	India extends price caps to 39 more medicines (Reuters)
09.07.15	Medicines Co. Authorizes Generic Launch Of Angiomax (RTTNews)
23.06.15	FDA Approves Medicines Co.'s Antiplatelet Drug Used During Heart Procedure (RTTNews)
01.06.15	The Medicines Company Announces Results of Phase 1 Study for Novel Investigational Intravenous Anesthetic, ABP-700 (Businesswire)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
01.05.15	Medicines Co. : FDA Approves Raplixa To Help Control Bleeding During Surgery (RTTNews)
20.04.15	Medicines Co. Says FDA Okays New Formulation Of MINOCIN For Injection (RTTNews)
16.04.15	Celsion Warms Up, AMGN Gets FDA Nod, SKBI Put On Notice, VVUS Sues Teva (RTTNews)
15.04.15	Pre-market Movers For April 15 (INTC, DAL, GOOGL, BAC, NOK, ALU, MDCO) (RTTNews)
10.04.15	Medicines Tastes Bitter, EXEL Excels, ORPN Has A Blast, FWP For The Long Haul (RTTNews)
09.04.15	Medicines Expects Weak Angiomax Sales To Hurt Q1 Revenue; Stock Down 9% (RTTNews)
02.04.15	India to add more AIDS, TB drugs in essential medicines list - sources (Reuters)
30.03.15	Medicines Company Receives Marketing Approval For EU Commission (RTTNews)
30.03.15	The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV® (oritavancin) and RAPLIXA™ (sealant powder) (Businesswire)
18.03.15	Unabhängige Studie bestätigt Senkung der Bivalirudin-assoziierten Mortalität und Blutungen bei Hoch-Risiko-Patienten mit akutem Koronarsyndrom, die sich einer PCI unterziehen (Businesswire)
26.01.15	New Drug Approvals - The Month That Was (RTTNews)
23.01.15	Medicines Co. Gets CHMP Positive Opinions For Kengrexal, Orbactiv And Raplixa (RTTNews)
23.01.15	The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) and RAPLIXA™ (sealant powder) (Businesswire)
28.10.14	AEZS To Watch Out, RCPT Surges In Afterhours, CEMI Focuses On Ebola, PTIE Hurt (RTTNews)
07.08.14	BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX (RTTNews)
09.07.14	The Medicines Company to Announce Second Quarter and First Half 2014 Financial Results on Wednesday, July 23, 2014 (Businesswire)
07.07.14	The Medicines Company erhält Erneuerung der Zulassung für Angiox® (Bivalirudin) von der Europäischen Arzneimittel-Agentur und der Europäischen Kommission (Businesswire)
07.07.14	The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission (Businesswire)
22.05.14	Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal (Businesswire)
22.05.14	AKTUELLE DATEN ZU ANGIOX (BIVALIRUDIN) BEI PATIENTEN MIT HERZINFARKT AUF DEM EUROPCR VORGESTELLT UND ZEITGLEICH IM EUROPEAN HEART JOURNAL VERÖFFENTLICHT (Businesswire)
23.04.14	Medicines Co. Agrees To Buy Tenaxis Medical - Quick Facts (RTTNews)
03.04.14	Medicines Co. Says FDA Accepts BLA For Fibrocaps - Quick Facts (RTTNews)
27.02.14	Medicines Co.'s MAA On Oritavancin Accepted In EU - Quick Facts (RTTNews)
19.02.14	Medicines Co. Q4 Profit Plunges (RTTNews)
14.02.14	DRRX Feels Pain, Bitter Pill For MDCO, RTRX Soars To New High, TRGT On Watch (RTTNews)
23.12.13	The Medicines Co. Says EMA Accepts Marketing Application For Cangrelor (RTTNews)
06.12.13	Boston Scientific & The Medicines Co. Announce U.S. Co-Promotion Deal (RTTNews)
04.12.13	Medicines Company Acquires Rempex Pharma - Quick Facts (RTTNews)
09.10.13	Critical Alerts For Groupon, ServiceNow, Trulia, Medicines, and Hanwha Solarone Released By InvestorsObserver (PR Newswire)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
09.10.13	Medicines Co. Enrolls First Patient In Phase III Trial Testing Angiomax (RTTNews)
17.09.13	Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest (PR Newswire)
03.09.13	Medicines Company Reports Pooled Analysis Of Cangrelor Phase III Trials (RTTNews)
30.08.13	Under AAAResearchReports.com Microscope: Life Technologies Corp., Opko Health Inc., Medicines Co., and DaVita Inc. (PR Newswire)
30.08.13	Under AAAResearchReports.com Microscope: Life Technologies Corp., Opko Health Inc., Medicines Co., and DaVita Inc. (PR Newswire)
14.08.13	Medicines Co. Prices Stock Offering (RTTNews)
13.08.13	Medicines Co. Launches Public Offering Of Up To 5.5 Mln Shares (RTTNews)
06.08.13	HNSN Jumps 22%, MDCO Reaches FINISH Line, SNY's Shot At Superbug Vaccine (RTTNews)
06.08.13	Medicines Co. Completes ProFibrix Acquisition (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

25.11.19		Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf
19.11.19		Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

25.11.19

Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf

19.11.19

Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	30.37	2.88 %	K V
Part Grp Hldg	1’330.00	2.39 %	K V
Roche Hldg G	271.80	1.84 %	K V
Givaudan	3’941.00	1.52 %	K V
Novartis	91.64	0.75 %	K V
Geberit	502.80	-0.59 %	K V
CieFinRichemont	139.55	-0.99 %	K V
Swiss Re	133.25	-1.15 %	K V
Zurich Insur Gr	540.00	-1.32 %	K V
Kuehne+Nagel Int	203.00	-2.12 %	K V

Nachrichten zu Medicines Co.

Aktien Top/Flop

Medicines Peer Group Nachrichten

Meistgelesene Nachrichten